ALB and neoplasm: The resultant nanocarriers were further modified with HSA-Gd hybrids (HGd) (PtMG@HGd) for MR imaging [53], and for the biocompatibility, stability, and tumor targeting ability (passive and active) of HSA [11] before the loading of indocyanine green (ICG) as the PS.